Hims & Hers Health (HIMS) - Update

Hims & Hers Health (HIMS) - Update
4 hour
In: Hims & Hers Health (HIMS), Healthcare & Biotechnology stocks, Our performance

2 out of 2 — this analysis has once again been a major success.

We are now officially deactivating our second Fibonacci retracement zone (the second grey zone) after it has played out perfectly.

Update from 31.03.2026

In our previous update on Hims & Hers, the stock entered the Fibonacci retracement zone we defined in our analysis from 27.02.2026 (https://monalytics.org/hims-hers-update/). This was the second Fibonacci retracement zone we identified for this market.

We expected that within this zone, the market would complete its short-term corrective phase and begin a new impulsive move — initiating the early stages of dark blue wave 3 and moving toward our defined price targets.

Hims & Hers has now officially validated this analysis and is approaching our projected targets, which are based on the following Fibonacci levels:

  • 161.8% at $41.02
  • 200% at $46.30
  • 261.8% at $54.85

These price targets serve as a guideline for where we realistically expect the stock could move. However, given the strong impulsive structure shown in recent trading sessions, the market could potentially extend beyond these levels.

We now officially mark a 100% hit rate on our analysis for this stock. If you entered at the upper boundary of the zone and held until today’s price, you would be up approximately 47% — a significant gain. However, we believe this may only be the beginning.

If any structural changes occur, or if new opportunities arise to buy or accumulate this stock based on our analysis, we will update you immediately.

Kind regards,
Monalytics

DISCLAIMER: The content on this website, including charts, analyses, and recommendations, is for informational purposes only and does not constitute financial, investment, or professional advice. Trading and investing involve risk. You should consult a qualified financial advisor before making any investment decisions.

More from MOnalytics
Great! You’ve successfully signed up.
Welcome back! You've successfully signed in.
You've successfully subscribed to MOnalytics.
Your link has expired.
Success! Check your email for magic link to sign-in.
Success! Your billing info has been updated.
Your billing was not updated.